Articles written by: Hugh Holland

Breaking: Wells Fargo Maintains $22 Target Price On CareTrust REIT (NASDAQ:CTRE) Shares, Maintains Their Original Outperform Rating

Breaking: Wells Fargo Maintains $22 Target Price On CareTrust REIT (NASDAQ:CTRE) Shares, Maintains Their Original Outperform Rating

CareTrust REIT (NASDAQ:CTRE) Rating Reaffirmed Wells Fargo now has a $22 TP on the $1.67B market cap company or 10.78 % upside potential. In an analyst report revealed to clients on 4 December, CareTrust REIT (NASDAQ:CTRE) shares have had their Outperform Rating reiterated by stock analysts at Wells Fargo. CareTrust […]

Metcash (MHTLY) Receives Lower Rating From Macquarie. What?s The Reasoning Behind This Move?

Metcash (MHTLY) Receives Lower Rating From Macquarie. What?s The Reasoning Behind This Move?

Metcash (MHTLY) Receives a Downgrade The Equity Rating of Metcash (MHTLY) rating was lowered by stock analysts at Macquarie from the previous “Neutral” rating to a “Underperform” rating in a report published on 4 December. It closed at $12.23 lastly. It is down 0.00% since December 4, 2017 and is […]

BMO Capital Reiterated Sienna Biopharmaceuticals (SNNA) As a “Outperform”; They Now Have a Price Target Of $17

Sienna Biopharmaceuticals (SNNA) Rating Reaffirmed Expert analysts at BMO Capital now has a $17 target price on Sienna Biopharmaceuticals (SNNA). BMO Capital and their recent target price indicates a potential upside of 190.10 % from the company’s stock close price. The rating has been revealed to investors in analysts report […]

Is Knight-Swift (NYSE:KNX) Now a Poor Investment? UBS Downgrades Shares

Is Knight-Swift (NYSE:KNX) Now a Poor Investment? UBS Downgrades Shares

Knight-Swift (NYSE:KNX) Receives a Downgrade In a note sent to clients and investors on Tuesday, 4 December, UBS has cut shares of Knight-Swift (NYSE:KNX) stock to a Neutral and has set an estimated 12-month target price equal to $36. KNX’s last stock rating by UBS was a Buy. Knight-Swift Transportation […]

Vanda Pharma (VNDA) Receives Upgrade From Cantor Fitzgerald. Will Other Analysts Follow Suit?

Vanda Pharma (VNDA) Receives Upgrade From Cantor Fitzgerald. Will Other Analysts Follow Suit?

Investors sentiment increased to 1.53 in 2018 Q2. Its up 0.57, from 0.96 in 2018Q1. It improved, as 10 investors sold Vanda Pharmaceuticals Inc. shares while 33 reduced holdings. 18 funds opened positions while 48 raised stakes. 47.64 million shares or 3.78% more from 45.90 million shares in 2018Q1 were […]

Vanda Pharma (NASDAQ:VNDA) Share Price May Be About to Change Direction; Cantor Fitzgerald Upgrades The Company.

Vanda Pharma (NASDAQ:VNDA) Share Price May Be About to Change Direction; Cantor Fitzgerald Upgrades The Company.

Investors sentiment increased to 1.53 in 2018 Q2. Its up 0.57, from 0.96 in 2018Q1. It increased, as 10 investors sold Vanda Pharmaceuticals Inc. shares while 33 reduced holdings. 18 funds opened positions while 48 raised stakes. 47.64 million shares or 3.78% more from 45.90 million shares in 2018Q1 were […]

Finally Time To Raise Your Stake? JP Morgan Upgrades Siam Cement (SCVPF) Shares

Siam Cement (SCVPF) Stock Upgrade JP Morgan increased shares of Siam Cement (SCVPF) to a solid Overweight rating from the previous Neutral. The change in rating was revealed in an analyst report today. It closed at $12.7 lastly. It is down 0.00% since December 4, 2017 and is . It […]

Will Investors Now Buy BT Group (NYSE:BT) Stock Following Today?s, Goldman Sachs Upgrades?

Will Investors Now Buy BT Group (NYSE:BT) Stock Following Today?s, Goldman Sachs Upgrades?

BT Group (NYSE:BT) Stock Upgrade It will be interesting to watch today’s trading of shares of BT Group (NYSE:BT) as Goldman Sachs increased the stock from a “Neutral” to a respectable “Buy”. The stock decreased 2.03% or $0.34 during the last trading session, reaching $16.37. About 667,553 shares traded. BT […]

Breaking: Mellanox Technologies (NASDAQ:MLNX) Buy Rating Reconfirmed by Analysts at Jefferies Today; The Target Price Given is $130

Breaking: Mellanox Technologies (NASDAQ:MLNX) Buy Rating Reconfirmed by Analysts at Jefferies Today; The Target Price Given is $130

Investors sentiment decreased to 1.51 in 2018 Q2. Its down 0.58, from 2.09 in 2018Q1. It turned negative, as 15 investors sold Mellanox Technologies, Ltd. shares while 56 reduced holdings. 54 funds opened positions while 53 raised stakes. 36.61 million shares or 1.75% more from 35.98 million shares in 2018Q1 […]

Is Buying TRXADE GROUP INC (OTCMKTS:TRXD), Having Lower Short Interest a Winning Strategy?

Is Buying TRXADE GROUP INC (OTCMKTS:TRXD), Having Lower Short Interest a Winning Strategy?

The stock of TRXADE GROUP INC (OTCMKTS:TRXD) registered a decrease of 50% in short interest. TRXD’s total short interest was 400 shares in December as published by FINRA. Its down 50% from 800 shares, reported previously. With 5,100 shares average volume, it will take short sellers 0 days to cover […]